More Than a Cure: Riley's Story and the Hope for Better Childhood Cancer Treatments
Six-year-old Riley has important things to do.
She's in first grade, keeping up with her three sisters and conquering the monkey bars. She loves gymnastics, swimming and riding her purple bike.
For her mom, Stephanie Cadiz, watching Riley enjoy these ordinary childhood moments means everything. Because just a few years ago, Riley struggled to walk.
At age 2, Riley was diagnosed with high-risk B-cell acute lymphoblastic leukemia. What followed was two and a half years of chemotherapy, blood transfusions, painful injections and countless hospital visits.
There were days when Riley was too weak to walk and wanted her parents to carry her. While other children played, Riley endured treatments that saved her life but took away so much of her childhood.
Today, Riley is doing well. She's back in school, full of energy and making up for lost time.
But her experience raises an important question: What if children could survive cancer without enduring so much along the way?
Researching a better future for children with cancer
Thanks to decades of research, survival rates for childhood acute lymphoblastic leukemia now approach 90%. But the treatments that save children's lives can also take a tremendous toll on their growing bodies.
At Versiti Blood Research Institute (VBRI), scientists are working toward a future where children have better options. And your generosity can help make that research possible.
Dr. Sid Rao is one of many dedicated VBRI researchers pursuing discoveries that could change how childhood blood cancers are treated. His work focuses on understanding the genetic changes that drive leukemia, with the goal of identifying more precise treatments that cause fewer harmful side effects.
Across VBRI, scientists are exploring new ways to fight aggressive leukemia, prevent cancer from returning and protect children's long-term health.
The next breakthrough could begin with a question scientists haven't answered yet. Your generosity gives them the opportunity to keep searching for answers that could change children's lives.
More childhood. More hope.
For Stephanie, that future can't come soon enough. She's grateful Riley is healthy and thriving. But she thinks about the children still facing cancer and the families hoping for better options.
RelatedInformation
Six VBRI Scientists Recognized on Stanford and Elsevier’s Top 2% List
Six Versiti Blood Research Institute scientists earned recognition on Stanford University and Elsevier’s World’s Top 2% Scientists list, highlighting the global influence of their research in blood health, immunology and medicine.
Impact Stories
Hope shows up in people. Explore firsthand stories of lifesaving blood, organ, and tissue gifts, including videos that honor the strength of patients and the generosity of donors.
Riley Cadiz
Three-year-old Riley was diagnosed with high-risk acute lymphoblastic leukemia in November 2022 and has received multiple blood and platelet transfusions to give her strength during grueling chemotherapy.
Versiti Blood Research Institute
Versiti Blood Research Institute investigators study blood disorders like hemophilia, blood cancers like leukemia, and other blood diseases.